Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease

Published Date:

10/19/09

Source:

HAN ; 299

Series:

HAN ; 299

Language:

English

[PDF-746.49 KB]

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Keywords:

[+]

Description:

Monday, October 19, 2009, 13:51 EDT (1:51 PM EDT)

CDCHAN-00299-2009-10-19-ADV-N

Summary Recommendations: When treatment of influenza is indicated in a patient with suspected influenza, health care providers should initiate empiric antiviral treatment as soon as possible. Waiting for laboratory confirmation of influenza to begin treatment with antiviral drugs is not necessary. Patients with a negative rapid influenza diagnostic test should be considered for treatment if clinically indicated because a negative rapid influenza test result does not rule out influenza virus infection. The sensitivity of rapid influenza diagnostic tests for 2009 H1N1 virus can range from 10% to 70%, indicating that false negative results occur frequently.

Document Type:

HAN Health Advisory

Collection(s):

Health Alert Network (HAN)

Place as Subject:

gau

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Respiratory Viral Testing and Influenza Antiviral Prescriptions During Hospitalization for Acute Respiratory Illnesses

Personal Author:

Rolfes, Melissa A.; Yousey-Hindes, Kimberly M.; Meek, James I.; Fry, Alicia M.; Chaves, Sandra S.;

Published:

Feb 12 2016

Source:

Open Forum Infect Dis. 2016; 3(1).

Description:

We examined respiratory viral testing and influenza antiviral prescriptions at a US tertiary care hospital. During the 2010-11 to 2012-13 influenza seasons, antiviral prescriptions among acute respiratory illness (ARI) hospitalizations were associate...

File Type:

[PDF - 179.80 KB]
Flu season begins : severe influenza illness reported : CDC urges rapid antiviral treatment of very ill and high risk suspect influenza patients without waiting for testing

Corporate Author:

Centers for Disease Control and Prevention (U.S.)

Published:

February 1, 2016,

Series:

HAN ; 387

Description:

February 1, 2016, 0850 EST (8:50 AM EST) : CDCHAN-00387 : Influenza activity is increasing across the country and CDC has received reports of severe influenza illness. Clinicians are reminded to treat suspected influenza in high-risk outpatients, tho...

File Type:

[PDF - 157.52 KB]
Influenza-Associated Intensive-Care Unit Admissions and Deaths — California, September 29, 2013–January 18, 2014

Personal Author:

Ayscue, Patrick; Murray, Erin; Uyeki, Timothy; Zipprich, Jennifer; Harriman, Kathleen; Salibay, Catheryn; Kang, Monica; Luu, Annie; Glenn-Finer, Rose; Watt, James; Glaser, Carol; Louie, Janice;

Published:

Feb 21 2014

Source:

MMWR Morb Mortal Wkly Rep. 2014; 63(7):143-147.

Description:

The California Department of Public Health (CDPH) conducts surveillance on severe influenza illness among California residents aged <65 years. Severe cases are defined as those resulting in admission to an intensive care unit (ICU) or death; reportin...

File Type:

[PDF - 270.74 KB]
Seasonal influenza A (H3N2) activity and antiviral treatment of patients with influenza

Corporate Author:

Centers for Disease Control and Prevention (U.S.)

Published:

December 27, 2017

Series:

HAN ; 409

Description:

December 27, 2017, 1030 ET (10:30 AM ET) : CDCHAN-00409 : The Centers for Disease Control and Prevention (CDC) is providing: 1) a notice about increased influenza A(H3N2) activity and its clinical implications; 2) a summary of influenza antiviral dru...

File Type:

[PDF - 511.47 KB]
Antiviral agents for the treatment and chemoprophylaxis of influenza; recommendations of the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Bresee, Joseph S.; Fiore, Anthony E.; Fry, Alica; Gubareva, Larisa V.; Shay, David K.; Uyeki, Timothy M.;

Corporate Author:

United States. Advisory Committee on Immunization Practices.; National Center for Immunization and Respiratory Diseases (U.S.); National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.; Centers for Disease Control and Prevention (U.S.);

Published:

January 21, 2011

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 60, no. 1

Description:

"This report updates previous recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of antiviral agents for the prevention and treatment of influenza (CDC. Prevention and control of influenza: recomm...

Status:

current

File Type:

[PDF - 24.76 MB]